Chorea

Evaluating the Effects of Treatment Conversion for Huntington's Chorea

Evaluating the Effects of Treatment Conversion for Huntington's Chorea

By

Overnight treatment conversion from tetrabenazine to deutetrabenazine in patients with HD was found to be safe.

Tardive Dyskinesia Treatment Approved by FDA

Tardive Dyskinesia Treatment Approved by FDA

By

Valbenazine is the first drug approved for the treatment of tardive dyskinesia, an adverse effect associated with the use of some antipsychotic medications.

Austedo Approved for Huntington's Chorea

Austedo Approved for Huntington's Chorea

By

Deutetrabenazine is only the second drug approved for patients with Huntington's disease.

Sign Up for Free e-newsletters



CME Focus